Jacob Greenwood Joins Project Farma (PF) as Vice President of Strategy
January 18, 2024
Project Farma (PF), a Patient Focused, People First organization, is growing their leadership team and has hired Jacob Greenwood as Vice President of Strategy. He brings extensive knowledge in industry, coupled with a diverse skill set at different levels within an organization, to help lead Project Farma into the future.
With over 10 years of business development and strategy experience in the biotech field, Jacob brings a comprehensive and diverse understanding of customer needs and the complex lifecycle that is drug development. Jacob served as the immediate past-President of the Chesapeake Bay Area Chapter of ISPE, where he is working to bring the community together through engaging and educational events.Jacob has been working in the Life Sciences sector since 2008. Spending a decade working in the lab as both a technician and a manager prior to moving into a business development role gives him a diverse understanding of customer needs. The ability to discuss project details from both the benchtop level and the 30,000-foot view has helped him develop meaningful connections with small startups as well as large organizations.
About Project Farma
Project Farma, a Precision for Medicine company, provides a biomanufacturing strategy and execution. Project Farma’s services include providing technical operations strategies such as pipeline evaluation and mobilization, make vs buy, and GMP infrastructure and startup. Additional services encompass strategy execution by managing capital projects, CDMO selection and management, tech transfers and facility builds and providing engineering services in automation, validation, quality, reliability and maintenance. Project Farma’s clients include startups, established life science corporations, advanced therapy organizations, universities, hospitals, government agencies, financial institutions, not-for-profits, and CROs/CMOs. For more information, visit projectfarma.com.
About Precision for Medicine
Precision for Medicine is the first biomarker-driven clinical research and development services organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments more precisely and effectively. Precision applies a transformational approach to clinical research that integrates clinical trial design and execution with deep scientific knowledge, laboratory expertise, data sciences and advanced manufacturing solutions. This convergence is driving faster clinical development and approval. Precision for Medicine is part of Precision Medicine Group, with 3,400 people in 40 locations globally across North America, Europe and Asia-Pacific. For more information, visit PrecisionForMedicine.com.
- About the Author
- Latest Posts
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.
